Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FSY34
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,357
Award facts
- Contract value 100% obligated
- $11,357.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,357.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on June 3, 2025, for the supply of Nucala 100 mg/ml auto-injector medications. The contract carries an ultimate completion date of June 4, 2025, and represents a standard delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. This award leverages the company's established presence as a critical supplier within the federal pharmaceutical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The IDC enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support medical supply needs across Department of Defense healthcare facilities. DMS Pharmaceutical Group has demonstrated consistent success in competing for federal pharmaceutical contracts since its registration in SAM.gov in 2001, with a robust portfolio of delivery orders covering diverse medical products spanning from specialty medications to vaccines and auto-injectors distributed to military and federal healthcare systems nationwide.
Quick answers
Who was awarded contract SPE2DB25FSY34?
SPE2DB25FSY34 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 3, 2025.
How much is contract SPE2DB25FSY34 worth?
The government has obligated $11,357 on SPE2DB25FSY34.
Is contract SPE2DB25FSY34 an order under another contract?
Yes. SPE2DB25FSY34 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FSY34 competed?
The extent of competition for SPE2DB25FSY34 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award